Teladoc Health (NYSE:TDOC) Shares Down 3.4% – Should You Sell?

Teladoc Health, Inc. (NYSE:TDOC)’s share price dropped 3.4% on Friday . The stock traded as low as $9.18 and last traded at $9.20. Approximately 890,929 shares traded hands during trading, a decline of 53% from the average daily volume of 1,878,147 shares. The stock had previously closed at $9.52.

Wall Street Analysts Forecast Growth

TDOC has been the topic of a number of recent analyst reports. Piper Sandler reissued an “overweight” rating and set a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Barclays increased their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. Jefferies Financial Group upped their price target on shares of Teladoc Health from $8.00 to $10.00 and gave the company a “hold” rating in a research note on Tuesday, September 17th. Royal Bank of Canada increased their target price on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Finally, TD Cowen cut their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.24.

Teladoc Health Stock Down 0.8 %

The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The company has a market cap of $1.63 billion, a PE ratio of -1.64 and a beta of 0.97. The company has a fifty day moving average price of $9.87 and a 200 day moving average price of $9.05.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.95% of the stock is currently owned by company insiders.

Institutional Trading of Teladoc Health

Several hedge funds and other institutional investors have recently made changes to their positions in TDOC. Versant Capital Management Inc increased its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares in the last quarter. TCW Group Inc. bought a new stake in Teladoc Health during the 3rd quarter worth approximately $2,464,000. Geode Capital Management LLC lifted its holdings in Teladoc Health by 1.5% during the third quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Teladoc Health during the 3rd quarter valued at $152,000. Finally, Quantinno Capital Management LP boosted its stake in shares of Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock worth $1,709,000 after acquiring an additional 122,050 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.